Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE (Details)

v3.23.3
SCHEDULE OF CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE (Details) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Jan. 12, 2022
Short-Term Debt [Line Items]      
Maturity Date Nov. 07, 2023    
Total notes payable $ 2,753 $ 7,018  
Debt discount (171) (408)  
Debt issuance costs (127) (309)  
Non-current (142) (1,215)  
Current $ 2,611 5,803  
Related Party Note Payable One [Member]      
Short-Term Debt [Line Items]      
Issuance Date [1] Dec. 01, 2015    
Maturity Date [1] Apr. 01, 2023    
Interest Rate [1] 12.00%    
Original Borrowing [1] $ 1,249    
Total notes payable [1] $ 725 725  
Related Party Note Payable Two [Member]      
Short-Term Debt [Line Items]      
Issuance Date [2] Apr. 04, 2016    
Maturity Date [2] Jun. 04, 2021    
Interest Rate [2] 12.00%    
Original Borrowing [2] $ 343    
Total notes payable [2] 40  
Note Payable [Member]      
Short-Term Debt [Line Items]      
Issuance Date [3] May 15, 2020    
Maturity Date [3] May 15, 2050    
Interest Rate [3] 3.75%    
Original Borrowing [3] $ 150    
Total notes payable [3] $ 142 150  
Convertible Notes Due 2023 [Member]      
Short-Term Debt [Line Items]      
Issuance Date [4] Jan. 12, 2022    
Maturity Date [4] Jan. 12, 2023    
Interest Rate 6.00% [4]   6.00%
Original Borrowing [4] $ 6,300    
Total notes payable [4] 1,350  
Promissory Note Payable [Member]      
Short-Term Debt [Line Items]      
Issuance Date [5] Nov. 07, 2022    
Maturity Date [5] May 07, 2024    
Interest Rate [5] 9.00%    
Original Borrowing [5] $ 5,470    
Total notes payable [5] $ 2,184 $ 5,470  
[1] On December 1, 2015, the Company issued a convertible note payable to Mr. Cutaia, the Company’s Chief Executive Officer and a director, to consolidate all loans and advances made by Mr. Cutaia to the Company as of that date. On May 19, 2021, the Company amended the note to allow for conversion of the note at any time at the discretion of the holder at a fixed conversion price of $41.20, which was the closing price of the common stock on the amendment date. On May 12, 2022, the maturity date of the note was extended to April 1, 2023. As of September 30, 2023 and December 31, 2022, the outstanding balance under the note was $876 and $811, respectively. As of September 30, 2023 and December 31, 2022, the portion of the outstanding balance that represents accrued interest was $151 and $86, respectively. See Note 14 for Subsequent Events.
[2] On April 4, 2016, the Company issued a convertible note payable to Mr. Cutaia, in the amount of $343, to consolidate all advances made by Mr. Cutaia to the Company during the period December 2015 through March 2016. On May 19, 2021, the Company amended the note to allow for conversion of the note at any time at the discretion of the holder at a fixed conversion price of $41.20, which was the closing price of the common stock on the amendment date. On September 20, 2023, the Company repaid all of the outstanding principal and accrued interest amounting to $48. As of September 30, 2023 and December 31, 2022, the outstanding balance under the note was $0 and $45, respectively. As of September 30, 2023 and December 31, 2022, the portion of the outstanding balance that represents accrued interest was $0 and $5, respectively.
[3] On May 15, 2020, the Company executed an unsecured loan with the SBA under the Economic Injury Disaster Loan program in the amount of $150. Installment payments, including principal and interest, began on October 26, 2022. In September 2022, the SBA approved an additional loan of $350. As of November 10, 2023, the Company has not received these funds. As of September 30, 2023 and December 31, 2022, the outstanding balance under the note was $142 and $150, respectively.
[4] On January 12, 2022, the Company entered into a securities purchase agreement (the “January Note Purchase Agreement”) with three institutional investors (collectively, the “January Note Holders”) providing for the sale and issuance of an aggregate original principal amount of $6,300 in convertible notes due January 2023 (each, a “Note,” and, collectively, the “Notes,” and such financing, the “January Note Offering”). The Company and the January Note Holders also entered into a security agreement, dated January 12, 2022, in connection with the January Note Offering, pursuant to which the Company granted a security interest to the January Note Holders in substantially all of its assets. The January Note Purchase Agreement prohibits the Company from entering into an agreement to effect any issuance of common stock involving a Variable Rate Transaction (as defined therein) during the term of the agreement, subject to certain exceptions set forth therein. The January Note Purchase Agreement also gives the January Note Holders the right to require the Company to use up to 15% of the gross proceeds raised from future debt or equity financings to redeem the Notes, which redemptions have been elected by the January Note Holders. There are no financial covenants related to these notes payable.
[5] On November 7, 2022, the Company entered into a note purchase agreement (the “November Note Purchase Agreement”) and promissory note with an institutional investor (the “November Note Holder”) providing for the sale and issuance of an unsecured, non-convertible promissory note in the original principal amount of $5,470, which has an original issue discount of $470, resulting in gross proceeds to the Company of approximately $5,000 (the “November Note,” and such financing, the “November Note Offering”). The November Note matures eighteen months following the date of issuance. Commencing nine months from the date of issuance, the Company is required to make monthly cash redemption payments in an amount not to exceed $600.